Navigation Links
Sahajanand Medical Technologies PAINT Trial Results Support Safety and Efficacy of the Infinnium and Supralimus Stents
Date:5/20/2008

Sahajanand Medical Technologies received positive results of nine month PAINT trials for Drug eluting stents, Infinnium and Supralimus. The results

unveiled during plenary session of EuroPCR 2008-Barcelona.

SURAT, India, May 20 /PRNewswire/ -- Sahajanand Medical Technologies Pvt. Ltd. (SMT), Surat, India, leading developer and manufacturer of drug-eluting stents, welcomed the positive results of the prospective, randomized nine months results of PAINT trial (PercutAneous INTervention with biodegradable- polymer based paclitaxel-eluting, sirolimus-eluting, or bare stents for the treatment of de novo coronary lesions).

The PAINT study was designed with a unique 3-arm format that allows the evaluation of three stents that only differ on the presence and/or type of drug (all stents have exactly the same material, strut thickness and platform design). This distinguishes the study from other comparative trials that aimed to assess the differences between Sirolimus and Paclitaxel (having different polymers and different platform).

The study hypothesizes that two novel formulations of stents with Paclitaxel (Infinnium) or Sirolimus (Supralimus), eluted in biodegradable polymers, are effective in reducing neointimal proliferation in comparison with bare metal stents.

The nine month results of PAINT, which were unveiled on Tuesday May 13th during the plenary session of EuroPCR 2008 -- Barcelona, Spain, demonstrated that in comparison with bare metal stents, both formulations of biodegradable-polymer Paclitaxel-eluting ( Infinnium ) and Sirolimus -eluting (Supralimus) stents are effective in reducing neointimal proliferation and the risk of repeat intervention at 270 days, without increasing the incidence of death or myocardial infarction.

Primary investigator, Dr Pedro Lemos of the Heart Institute (InCor) University of Sao Paulo Medical School, Brazil, commented that, "The design of PAINT (2:2:1 randomization of 280 patient w
'/>"/>

SOURCE Sahajanand Medical Technologies Pvt. Ltd.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...2 PDL BioPharma, Inc. (P...stablished the per share amount of the previously ...er share. The dividend will be paid on December 15... the December 1, 2009 record date. NASDAQ had prev...of the dividend at $1.67 per share of common stock...
(Date:12/2/2009)... 2 Clarient, Inc. (Nasda...urce for pathologists, oncologists and the pharmac...l Officer transition plan that calls for veteran f...its Senior Vice President and Chief Financial Offi...the current Senior Vice President and Chief Financ...
(Date:12/2/2009)... Dec. 2 Novartis announced today t...on on Tasigna® (nilotinib) 200 mg capsules in...he strength of the company,s hematology portfolio ...data, at the 51st American Society of Hematology (...company,s current therapies and investigational ag...
Breaking Medicine Technology:PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 2PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 3Clarient Announces CFO Transition Plan 2Clarient Announces CFO Transition Plan 3Clarient Announces CFO Transition Plan 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of Take Charge Workshops for the Unemployed 12423 1Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of Take Charge Workshops for the Unemployed 12423 2Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of Take Charge Workshops for the Unemployed 12423 3Walsh College and Ford Motor Company Fund and Community Services Team Up To Offer New Series of Take Charge Workshops for the Unemployed 12423 4External beam partial breast irradiation most cost effective treatment 47644 1External beam partial breast irradiation most cost effective treatment 47644 2Researchers call for new space headache category following astronauts survey 47642 1Researchers call for new space headache category following astronauts survey 47642 2
... 20, 2007 /PRNewswire-USNewswire/ -- The,Christoph...,non-profit organization dedicated to finding cure...oving the lives of people living,with paralysis, t...Bush,s veto of the Stem Cell Research Enhancement ...ts in stem cell research with the,support and over...
...RE)--Jun 20, 2007 - Today, President Bush,Signed A...tment To,Research On Pluripotent Stem Cells. Scien...and skill to pursue the potential benefits,of plur...t have the,potential to develop into nearly all th...angering human life in the process. By,expanding s...
Other Medicine Technology:The Christopher and Dana Reeve Foundation Expresses Disappointment,Over President Bush's Veto of the Stem Cell Research Enhancement,Act 2The Christopher and Dana Reeve Foundation Expresses Disappointment,Over President Bush's Veto of the Stem Cell Research Enhancement,Act 3Fact Sheet: Advancing Stem Cell Research While Respecting Moral,Boundaries 2Fact Sheet: Advancing Stem Cell Research While Respecting Moral,Boundaries 3
(Date:12/2/2009)... Care Support of America,s model ...ced Illness Coordinated Care (AICC) , has been sho... life as well as improve the quality of life for s...ing mortality. These are the principal findings of...aged Care (November 2009). ,, Based on a r...
(Date:12/2/2009)...An avid tennis player and golfer, as well as baseb...creasingly frustrated over time as his eyesight di...er. Unable to return the tennis ball or see the pi...orneal transplant to restore his vision and eye co...d an alternative treatment. He received a gas perm...
(Date:12/2/2009)... been a top name in the medical supply industry si... professional staff, and a keen understanding of t...stablished itself as a provider of ground ambulanc...supplies distributor. The distinguished history of...ext phase with the redesign and launch of its webs...
(Date:12/2/2009)...Newswire/ -- The American Health Information Manag...nced Alan F. Dowling, PhD, will be the next chief ...management (HIM) leader. Dr. Dowling,s extensive ...ystems management, strategic expertise, governance...ship. He is scheduled to take office January 13, ...
(Date:12/2/2009)...swire-USNewswire/ -- At a recently concluded first...gates came together to outline the future of medic...ecessary thrust. Organized by the Medical Tourism ....com , the high-powered congregation of senior min...es and requests for assistance in medical tourism ...
Breaking Medicine News(10 mins):Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 2Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 3Health News:Outpatient Palliative Care Reduces Hospitalizations, Which Impact Costs, While Improving Quality of Life for Seniors and Family Caregivers - New Study in American Journal of Managed Care 4Health News:Brandeis studies evaluate visionary approach to improving eyesight 2Health News:From A to B and Everything In-between; AB First Aid Launch New Web Storefront 2Health News:From A to B and Everything In-between; AB First Aid Launch New Web Storefront 3Health News:Dr. Alan F. Dowling Named AHIMA's Next Chief Executive Officer 2Health News:Ministerial Roundtable Discusses Future of Medical Tourism 2Health News:Ministerial Roundtable Discusses Future of Medical Tourism 3
...20 Lincare Holdings,Inc. (Nasdaq: LNCR ), a lead...py services delivered to patients in the home, tod...ine months ended September 30, 2008., For the qua...tes that the change in net revenues was comprised ...
...treatments less effective, more painful than singu...Day News) -- Laser therapies to remove unwanted ha...ately rather than in combination, according to an ...sing either long-pulsed 755-nanometer alexandrite ...
...n 330,000 lives were lost to HIV/AIDS in South Afr...ly antiretroviral (ARV) treatment program was not ...chool of Public Health (HSPH) in a study published...with HIV during that same period in the country be...
...ntists: Highlights of the Bush Presidency - A Plea...ey Among Health Advocates Reveals Chemical Exposur...t Impacts Public Health Presidential candidates a...on official representing EPA scientists, and many,...
...isoners who have hepatitis C with the standard the...e cost-effective, says a new study in the November...n Wiley & Sons on behalf of the American Associati...s incarcerate more than 2 million inmates each yea...
...e Duty Service Members to Be Served Beginning in ..., Pa., Oct. 20 United Concordia Companies,Inc. ha...ogram (ADDP),contract by the United States Departm...valued at approximately,$660 million, will begin A...
Other Medicine News:Health News:Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2008 Financial Results 2Health News:Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2008 Financial Results 3Health News:Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2008 Financial Results 4Health News:Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2008 Financial Results 5Health News:Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2008 Financial Results 6Health News:Study Evaluates Laser Therapies for Hair Removal 2Health News:Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa 2Health News:Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa 3Health News:Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa 4Health News:Human Testing - Exposing Children to Chemicals 2Health News:Hepatitis C treatment is cost-effective for the US prison population 2Health News:National Dental Insurer United Concordia to Receive $660 Million Contract From U.S. Department of Defense 2
...ch control panel with 3 charging wells. Available ... and Cinnamon. Spring balanced refractor and slit ...n for lifelong quality. Sealed hydraulic system fo...t. Chair back reclines manually to fully horizonta...
...oped the patented HydroKeratome corneal cutting de...d industry experts believe it will replace the aut...atome, currently used in the LASIK refractive proc...any has demonstrated that its proprietary technolo...
2.5v Ophthalmoscope Set
3.5v Coaxial Ophthalmoscope Set
Medicine Products: